<p>% differences in primary outcomes at 6 months (main analysis), 12, 24 and 48 months.</p
<p>Outcomes at baseline and 12 months, and linear mixed models-based estimated difference (β) of int...
<p>Proportion of patients with (A) 6-month and (B) 12-month confirmed EDSS progression during months...
Comparison of perinatal outcomes and small for gestational age rates between groups.</p
<p>Comparison of primary outcome and variants between trial arms through 12 months postpartum.</p
A comparison of the primary outcome, HbA1c, throughout the 6-month follow-up.</p
Primary and secondary outcome measures at baseline and three-month follow-up.</p
<p>Percent of patients in each group who reached the primary endpoint at 3 months (p = 0.43).</p
<p>Changes in primary and secondary outcomes for all participants from baseline to three months.</p
<p>Mean difference between paired observations at baseline and month 12 in patients with baseline an...
Per-protocol analyses for the primary and key secondary outcome after 24 monthsa.</p
Comparisons of baseline characteristics according to a 3-month functional outcome based on mRS score...
Comparisons between baseline and 12 weeks across all self-reported health outcomes.</p
Outcomes at 12 months follow-up compared between the intervention and the control groups.</p
<p>Change from baseline to 3 months in primary and secondary outcomes (3-month value minus baseline ...
<p>Figures are median number of days and IQR in parentheses except for DST laboratory TAT >60 days, ...
<p>Outcomes at baseline and 12 months, and linear mixed models-based estimated difference (β) of int...
<p>Proportion of patients with (A) 6-month and (B) 12-month confirmed EDSS progression during months...
Comparison of perinatal outcomes and small for gestational age rates between groups.</p
<p>Comparison of primary outcome and variants between trial arms through 12 months postpartum.</p
A comparison of the primary outcome, HbA1c, throughout the 6-month follow-up.</p
Primary and secondary outcome measures at baseline and three-month follow-up.</p
<p>Percent of patients in each group who reached the primary endpoint at 3 months (p = 0.43).</p
<p>Changes in primary and secondary outcomes for all participants from baseline to three months.</p
<p>Mean difference between paired observations at baseline and month 12 in patients with baseline an...
Per-protocol analyses for the primary and key secondary outcome after 24 monthsa.</p
Comparisons of baseline characteristics according to a 3-month functional outcome based on mRS score...
Comparisons between baseline and 12 weeks across all self-reported health outcomes.</p
Outcomes at 12 months follow-up compared between the intervention and the control groups.</p
<p>Change from baseline to 3 months in primary and secondary outcomes (3-month value minus baseline ...
<p>Figures are median number of days and IQR in parentheses except for DST laboratory TAT >60 days, ...
<p>Outcomes at baseline and 12 months, and linear mixed models-based estimated difference (β) of int...
<p>Proportion of patients with (A) 6-month and (B) 12-month confirmed EDSS progression during months...
Comparison of perinatal outcomes and small for gestational age rates between groups.</p
DOI
Add to ORKG